• About
      • Back
      • About IPL
      • Management Team
      • Board of Directors
  • Pipeline
  • Therapeutic Areas
  • Clinical Trials
  • Technology
  • News & Publications
      • Back
      • Press Releases
      • Media
      • Publications
  • Contact

We're Making News

Media

ALS News Today: IPL344 slows ALS progression in trial, data suggest

13 April 2025
Read More

ALS News Today: Investigational Treatment IPL344 Safely Slows ALS Progression in Small Phase 1/2a Trial

9 December 2023
Read More

Neurology Live: Akt Activator IPL344 Demonstrates Safety, Signs of Efficacy in Phase 1/2 Study of ALS

4 November 2022
Read More

ALS News Today: IPL344

8 December 2020
Read More

© 2025 Immunity Pharma Ltd.
LiveSites